Becton Dickinson Price to Book Ratio 2012-2026 | BDX
Historical price to book ratio values for Becton Dickinson (BDX) over the last 10 years. The current price to book ratio for Becton Dickinson as of September 16, 2026 is 2.10.
| Becton Dickinson Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 181.85 | 2.03 | |
| 2026-06-30 | 150.44 | $89.64 | 1.68 |
| 2026-03-31 | 155.21 | $87.46 | 1.77 |
| 2025-12-31 | 149.66 | $88.66 | 1.69 |
| 2025-09-30 | 143.56 | $88.96 | 1.61 |
| 2025-06-30 | 131.40 | $88.87 | 1.48 |
| 2025-03-31 | 173.69 | $88.07 | 1.97 |
| 2024-12-31 | 171.25 | $87.78 | 1.95 |
| 2024-09-30 | 181.13 | $89.55 | 2.02 |
| 2024-06-30 | 174.86 | $89.50 | 1.95 |
| 2024-03-31 | 184.41 | $88.62 | 2.08 |
| 2023-12-31 | 180.98 | $87.68 | 2.06 |
| 2023-09-30 | 191.11 | $88.83 | 2.15 |
| 2023-06-30 | 194.49 | $89.40 | 2.18 |
| 2023-03-31 | 181.70 | $90.45 | 2.01 |
| 2022-12-31 | 185.94 | $89.72 | 2.07 |
| 2022-09-30 | 162.33 | $89.22 | 1.82 |
| 2022-06-30 | 178.99 | $89.39 | 2.00 |
| 2022-03-31 | 187.78 | $86.03 | 2.18 |
| 2021-12-31 | 176.95 | $84.84 | 2.09 |
| 2021-09-30 | 172.36 | $83.23 | 2.07 |
| 2021-06-30 | 169.96 | $84.04 | 2.02 |
| 2021-03-31 | 169.35 | $85.37 | 1.98 |
| 2020-12-31 | 173.68 | $84.88 | 2.05 |
| 2020-09-30 | 160.95 | $81.94 | 1.96 |
| 2020-06-30 | 164.95 | $82.87 | 1.99 |
| 2020-03-31 | 157.88 | $77.09 | 2.05 |
| 2019-12-31 | 186.26 | $78.19 | 2.38 |
| 2019-09-30 | 172.72 | $77.95 | 2.22 |
| 2019-06-30 | 171.56 | $79.63 | 2.15 |
| 2019-03-31 | 169.46 | $79.00 | 2.15 |
| 2018-12-31 | 152.42 | $79.55 | 1.92 |
| 2018-09-30 | 175.99 | $78.27 | 2.25 |
| 2018-06-30 | 161.07 | $79.82 | 2.02 |
| 2018-03-31 | 145.23 | $79.16 | 1.83 |
| 2017-12-31 | 142.97 | $79.80 | 1.79 |
| 2017-09-30 | 130.42 | $56.80 | 2.30 |
| 2017-06-30 | 129.39 | $55.31 | 2.34 |
| 2017-03-31 | 121.19 | $37.33 | 3.25 |
| 2016-12-31 | 108.93 | $35.63 | 3.06 |
| 2016-09-30 | 117.74 | $35.79 | 3.29 |
| 2016-06-30 | 110.68 | $37.73 | 2.93 |
| 2016-03-31 | 98.70 | $36.13 | 2.73 |
| 2015-12-31 | 99.73 | $34.10 | 2.92 |
| 2015-09-30 | 85.49 | $34.00 | 2.51 |
| 2015-06-30 | 90.89 | $34.50 | 2.63 |
| 2015-03-31 | 91.74 | $34.19 | 2.68 |
| 2014-12-31 | 88.55 | $26.27 | 3.37 |
| 2014-09-30 | 72.11 | $26.33 | 2.74 |
| 2014-06-30 | 74.60 | $28.03 | 2.66 |
| 2014-03-31 | 73.49 | $27.51 | 2.67 |
| 2013-12-31 | 69.03 | $26.31 | 2.62 |
| 2013-09-30 | 62.17 | $26.00 | 2.39 |
| 2013-06-30 | 61.12 | $24.29 | 2.52 |
| 2013-03-31 | 58.84 | $23.62 | 2.49 |
| 2012-12-31 | 47.85 | $23.04 | 2.08 |
| 2012-09-30 | 47.77 | $21.00 | 2.27 |
| 2012-06-30 | 45.18 | $21.22 | 2.13 |
| 2012-03-31 | 46.65 | $22.08 | 2.11 |
| 2011-12-31 | 44.62 | $22.50 | 1.98 |
| 2011-09-30 | 43.52 | $22.48 | 1.94 |
| 2011-06-30 | 50.88 | $24.37 | 2.09 |
| 2011-03-31 | 46.78 | $23.31 | 2.01 |
| 2010-12-31 | 49.40 | $22.06 | 2.24 |
| 2010-09-30 | 43.10 | $23.65 | 1.82 |
| 2010-06-30 | 39.12 | $22.20 | 1.76 |
| 2010-03-31 | 45.31 | $22.07 | 2.05 |
| 2009-12-31 | 45.17 | $22.32 | 2.02 |
| 2009-09-30 | 39.76 | $21.69 | 1.83 |
| 2009-06-30 | 40.45 | $21.77 | 1.86 |
| 2009-03-31 | 37.96 | $20.06 | 1.89 |
| 2008-12-31 | 38.41 | $19.89 | 1.93 |
| 2008-09-30 | 44.84 | $20.30 | 2.21 |
| 2008-06-30 | 45.27 | $20.83 | 2.17 |
| 2008-03-31 | 47.64 | $19.91 | 2.39 |
| 2007-12-31 | 46.23 | $18.54 | 2.49 |
| 2007-09-30 | 45.23 | $17.89 | 2.53 |
| 2007-06-30 | 40.93 | $17.37 | 2.36 |
| 2007-03-31 | 42.11 | $16.86 | 2.50 |
| 2006-12-31 | 38.29 | $16.07 | 2.38 |
| 2006-09-30 | 38.45 | $15.63 | 2.46 |
| 2006-06-30 | 33.15 | $14.53 | 2.28 |
| 2006-03-31 | 33.28 | $14.19 | 2.35 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $51.228B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |